Thrombin inhibitors based on ketone derivatives of arginine and lysine.

Much attention is currently focused on inhibitors of thrombin as potential anticoagulants. We have previously reported thrombin inhibitors based on fragments of fibrinogen containing a ketomethylene isostere at P1-P'1. We now expand on these early findings by reporting on tripeptide based inhibitors of thrombin containing arginine or lysine ketones at the C-terminus. A large variety of such ketones have been studied and compared in their ability to increase the thrombin time in human plasma. In the case of arginine or lysine ketones the order of activity (i.e. decreasing IC50 TT) was: alkyl ketones < beta-ketoesters < difluoro beta-ketoamides < alkyloxymethyl ketones < fluoroketones. Lysine analogues were generally found to be ca. ten-fold less active than their arginine counterparts. However, in the case of alpha-ketoesters the lysine derivatives were superior to all the types of arginine ketones studied (including the arginine alpha-keto ester derived thrombin inhibitor). A mechanistic explanation of the relative inactivity of the arginine alpha-keto ester derivative is proposed. All the highly electrophilic ketones were found to be slow-binding with thrombin.

[1]  Professor Dr. Miklos Bodanszky,et al.  The Practice of Peptide Synthesis , 1994, Springer Lab Manual.

[2]  F. Ofosu,et al.  Understanding thrombin and hemostasis. , 1993, Hematology/oncology clinics of North America.

[3]  J. Chong Regioselective reduction of 2,3-epoxy alcohol derivatives. An efficient route to enantiomerically pure 2-alkanols , 1992 .

[4]  J. Feijen,et al.  Promotion of endothelial coverage and decrease of platelet reactivity of artificial surfaces using monoclanal antibodies directed against endothelial cells , 1991 .

[5]  S. Matsunaga,et al.  Bioactive marine metabolites. 33. Cyclotheonamides, potent thrombin inhibitors, from a marine sponge Theonella sp , 1990 .

[6]  M. Dioszegi,et al.  Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-H. , 1990, Journal of medicinal chemistry.

[7]  M. García-López,et al.  An improved one-pot method for the stereoselective synthesis of the (2S,3R)-3-amino-2-hydroxy acids: key intermediates for bestatin and amastatin , 1990 .

[8]  N. Peet,et al.  Alpha-diketone and alpha-keto ester derivatives of N-protected amino acids and peptides as novel inhibitors of cysteine and serine proteinases. , 1990, Journal of medicinal chemistry.

[9]  Y. Kiso,et al.  A SIMPLE DIASTEREOSELECTIVE SYNTHESIS OF CYCLOHEXYLNORSTATINE AND ALLOCYCLOHEXYLNORSTATINE , 1989 .

[10]  J. Schloss Significance of slow-binding enzyme inhibition and its relationship to reaction-intermediate analogs , 1988 .

[11]  D. Rich,et al.  A facile synthesis of statine and analogs by reduction of .beta.-keto esters derived from Boc-protected amino acids. HPLC analyses of their enantiomeric purity , 1988 .

[12]  N. Peet,et al.  Oxidation of α-hydroxy esters to α-keto esters using the dess-martin periodinane reagent , 1988 .

[13]  N. Weber,et al.  Biologically active lipids Semi‐synthesis of3H‐labeled ether glycerophospholipids and ether glyceroglycolipids from ratfish liver oil , 1987, FEBS letters.

[14]  C. Hassall,et al.  Synthesis and structure-activity relationships of antibacterial phosphonopeptides incorporating (1-aminoethyl)phosphonic acid and (aminomethyl)phosphonic acid. , 1986, Journal of medicinal chemistry.

[15]  T. Kitazume,et al.  Ultrasound-promoted selective perfluoroalkylation on the desired position of organic molecules , 1985 .

[16]  J. McMurray,et al.  A Simple and Convenient Method for the Preparation of Ketomethylene Peptide Analogues , 1985 .

[17]  G. Jahreis,et al.  Synthesis and Properties of Peptide Ketones , 1983 .

[18]  C. Djerassi,et al.  Synthesis of (23R)- and (23S)-methylcholesterol , 1983 .

[19]  M. Szelke,et al.  Potent new inhibitors of human renin , 1982, Nature.

[20]  T. Kitazume,et al.  TRIFLUOROMETHYLATION OF CARBONYL COMPOUNDS WITH TRIFLUOROMETHYLZINC IODIDE UNDER ULTRASONIC IRRADIATION , 1981 .

[21]  N. Benoiton,et al.  A Simple Preparation of 5-Oxo-4,5-dihydro-1,3-oxazoles (Oxazolones) , 1979 .

[22]  G. Höfle,et al.  4‐Dialkylaminopyridines as Highly Active Acylation Catalysts. [New synthetic method (25)] , 1978 .

[23]  I. Ugi,et al.  Der 2,2,2‐Trichlor‐tert‐butyloxycarbonyl‐(TCBOC)‐Rest, eine säure‐ und basestabile, schonend abspaltbare Schutzgruppe , 1978 .

[24]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[25]  J. Lewis,et al.  Differential diagnosis and treatment in hemorrhagic disease. , 1957, A.M.A. archives of internal medicine.